Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles S Fuchs

Showing results (51-60 of 671) with videos related to

Pageof 68
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Relationship of baseline serum bilirubin to efficacy and toxicity of single-agent irinotecan in patients with metastatic colorectal cancerJeffrey A Meyerhardt, Ambrose Kwok, Mark J Ratain, et al.
American Journal of Epidemiology|June 11, 2003
Dietary meat, dairy products, fat, and cholesterol and pancreatic cancer risk in a prospective studyDominique S Michaud, Edward Giovannucci, Walter C Willett, et al.
Cancer|September 24, 2005
Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinomaBruce E Hillner, Deborah Schrag, Daniel J Sargent, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Polymorphism in the thymidylate synthase promoter enhancer region and risk of colorectal adenomasJia Chen, Charles Kyte, Wendy Chan, et al.
Human Pathology|January 24, 2007
Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotypeShuji Ogino, Takako Kawasaki, Akiyo Ogawa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 7, 2006
Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMPShuji Ogino, Takako Kawasaki, Gregory J Kirkner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 16, 2006
Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysisShuji Ogino, Mohan Brahmandam, Takako Kawasaki, et al.
Journal of the National Cancer Institute|November 17, 2005
Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective studyEsther K Wei, Edward Giovannucci, Charles S Fuchs, et al.
Cancer Causes & Control : CCC|May 15, 2008
Association of the TCF7L2 polymorphism with colorectal cancer and adenoma riskAditi Hazra, Charles S Fuchs, Andrew T Chan, et al.
The American Journal of Clinical Nutrition|January 6, 2012
Alcohol consumption and the risk of colon cancer by family history of colorectal cancerEunyoung Cho, Jung Eun Lee, Eric B Rimm, et al.
Pageof 68

Showing results (51-60 of 671) with videos related to

Sort By:
Pageof 68
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Relationship of baseline serum bilirubin to efficacy and toxicity of single-agent irinotecan in patients with metastatic colorectal cancerJeffrey A Meyerhardt, Ambrose Kwok, Mark J Ratain, et al.
American Journal of Epidemiology|June 11, 2003
Dietary meat, dairy products, fat, and cholesterol and pancreatic cancer risk in a prospective studyDominique S Michaud, Edward Giovannucci, Walter C Willett, et al.
Cancer|September 24, 2005
Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinomaBruce E Hillner, Deborah Schrag, Daniel J Sargent, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Polymorphism in the thymidylate synthase promoter enhancer region and risk of colorectal adenomasJia Chen, Charles Kyte, Wendy Chan, et al.
Human Pathology|January 24, 2007
Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotypeShuji Ogino, Takako Kawasaki, Akiyo Ogawa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 7, 2006
Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMPShuji Ogino, Takako Kawasaki, Gregory J Kirkner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 16, 2006
Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysisShuji Ogino, Mohan Brahmandam, Takako Kawasaki, et al.
Journal of the National Cancer Institute|November 17, 2005
Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective studyEsther K Wei, Edward Giovannucci, Charles S Fuchs, et al.
Cancer Causes & Control : CCC|May 15, 2008
Association of the TCF7L2 polymorphism with colorectal cancer and adenoma riskAditi Hazra, Charles S Fuchs, Andrew T Chan, et al.
The American Journal of Clinical Nutrition|January 6, 2012
Alcohol consumption and the risk of colon cancer by family history of colorectal cancerEunyoung Cho, Jung Eun Lee, Eric B Rimm, et al.
Pageof 68